Limited Competition for Establishing Pilot/Opportunity program for AI Models to Accelerate Diabetes Research (U24- Clinical Trials not allowed)
Agency: National Institutes of Health
- 93.847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research
Archived opportunityLast Updated: Jul 20, 2026
Important dates
- Archived: July 21, 2026
- Closed: Not specified
Award details
- Expected project funding: Not specified
- Expected awards: Not specified
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:RFA-DK-26-314
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Posted date: September 25, 2025
- Archive date: July 21, 2026
- Version: 3
Summary
Diabetes has become a major public health challenge due to its high prevalence and chronic nature, with many individuals managing the condition for decades. One major challenge in diabetes is the enormous heterogeneity associated with the disease, which necessitates personalized approaches to its prevention, diagnosis, treatment, and prognosis. To address this, the research field has generated a large amount of complex data, and has accumulated vast prior knowledge about the disease. These data and prior knowledge contain critical, but mostly hidden, information relevant to solving this challenge. However, major hurdles exist in integrating them and extracting predictive signals, including a lack of data science expertise in the diabetes research field and the absence of diabetes-specific data science and AI expert systems, models, and tools. This initiative proposes to address these issues by establishing a pilot funding program that leverages the emerging opportunities from recent data science and AI advances. It will recruit multidisciplinary teams that include both diabetes and data science experts, to (1) develop AI foundation models for diabetes; (2) validate the models with top research questions in diabetes heterogeneity; (3) disseminate the models and engagement the community for further development, validation and application, and; (4) develop use cases that demonstrate models’ potential in accelerating the tempo of research. The expected outcomes include the integration of new AI experts into the diabetes research workforce, the creation of AI models that the average diabetes researcher can use, and informative use cases demonstrating the models' potential.
Eligibility
Miscellaneous
- Other
Additional information on eligibility
Documents
No documents are currently available.
Agency contact information
Email: xujing.wang@nih.gov
xujing.wang@nih.gov
Link to additional information
No additional information is available
HHS.gov
An official website of the U.S. Department of Health and Human Services
